BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17266140)

  • 1. Contributions of OMERACT to rheumatic disease research.
    Singh JA; Solomon DH; Dougados M; Felson D; Hawker G; Katz P; Paulus H; Siegel J; Wallace C
    Arthritis Rheum; 2007 Feb; 57(1):186. PubMed ID: 17266140
    [No Abstract]   [Full Text] [Related]  

  • 2. OMERACT 6 brings new perspectives to rheumatology measurement research.
    Saag KG
    J Rheumatol; 2003 Apr; 30(4):639-41. PubMed ID: 12672177
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment outcome parameters].
    Burmester GR; Smolen J
    Z Rheumatol; 2009 Feb; 68(1):9. PubMed ID: 19156433
    [No Abstract]   [Full Text] [Related]  

  • 4. The OMERACT filter for Outcome Measures in Rheumatology.
    Boers M; Brooks P; Strand CV; Tugwell P
    J Rheumatol; 1998 Feb; 25(2):198-9. PubMed ID: 9489805
    [No Abstract]   [Full Text] [Related]  

  • 5. OMERACT 10--International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials.
    Brooks P; Boers M; Simon LS; Strand V; Tugwell P; Idzerda L
    J Rheumatol; 2011 Jul; 38(7):1450-51. PubMed ID: 21724714
    [No Abstract]   [Full Text] [Related]  

  • 6. The World Health Organisation International Classification of Functioning, Disability and Health: a conceptual model and interface for the OMERACT process.
    Stucki G; Boonen A; Tugwell P; Cieza A; Boers M
    J Rheumatol; 2007 Mar; 34(3):600-6. PubMed ID: 17343306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The OMERACT-ICF Reference Group: integrating the ICF into the OMERACT process: opportunities and challenges.
    Boonen A; Stucki G; Maksymowych W; Rat AC; Escorpizo R; Boers M;
    J Rheumatol; 2009 Sep; 36(9):2057-60. PubMed ID: 19738213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonpharmacologic interventions need outcomes for evaluating complex interventions in rheumatic diseases.
    Guillemin F; Iversen MD; Rat AC; Osborne R; Petersson IF
    J Rheumatol; 2011 Aug; 38(8):1803-5. PubMed ID: 21807804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders.
    Tubach F; Ravaud P; Beaton D; Boers M; Bombardier C; Felson DT; van der Heijde D; Wells G; Dougados M
    J Rheumatol; 2007 May; 34(5):1188-93. PubMed ID: 17477485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platonic outcomes.
    Fries JF; Ramey DR
    J Rheumatol; 1993 Mar; 20(3):415-7. PubMed ID: 8478844
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient perspective on outcomes in rheumatology -- a position paper for OMERACT 9.
    Kirwan JR; Newman S; Tugwell PS; Wells GA
    J Rheumatol; 2009 Sep; 36(9):2067-70. PubMed ID: 19738215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings of OMERACT 10, the International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials. May 4-8, 2010. Kota Kinabalu, Borneo.
    J Rheumatol; 2011 Jul; 38(7):1448-518. PubMed ID: 22263235
    [No Abstract]   [Full Text] [Related]  

  • 13. Ambulatory care-sensitive hospitalizations: does one size fit all?
    Losina E; Katz JN
    Arthritis Rheum; 2008 Feb; 59(2):159-61. PubMed ID: 18240178
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings of OMERACT 9: International Consensus Conference on Outcome Measures in Rheumatology, Kananaskis Village, Alberta, Canada, May 27-31, 2008.
    J Rheumatol; 2009 Sep; 36(9):2045-121. PubMed ID: 19911439
    [No Abstract]   [Full Text] [Related]  

  • 15. Bibliography. Current world literature. Epidemiology and health-related services.
    Curr Opin Rheumatol; 2007 Mar; 19(2):204-25. PubMed ID: 17278939
    [No Abstract]   [Full Text] [Related]  

  • 16. Data collection, maintenance, and analysis for rheumatic disease research.
    Wolfe F; Michaud K
    Rheum Dis Clin North Am; 2004 Nov; 30(4):753-68, vi. PubMed ID: 15488691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OMERACT IV. Outcome Measures in Rheumatology. Cancún, Mexico, April 16-20, 1998.
    J Rheumatol; 1999 Feb; 26(2):459-507. PubMed ID: 10391752
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rheumatology in 2008. The Danish Society of Rheumatology].
    Madsen OR; Sørensen IJ; Kjaer M; Schiøttz-Christensen B; Bliddal H; Østergaard M;
    Ugeskr Laeger; 2008 Mar; 170(12):1054. PubMed ID: 18397672
    [No Abstract]   [Full Text] [Related]  

  • 19. The OMERACT Initiative. Towards a reference approach to derive QALY for economic evaluations in rheumatology.
    Boonen A; Maetzel A; Drummond M; Suarez-Almazor M; Harrison M; Welch V; Tugwell PS
    J Rheumatol; 2009 Sep; 36(9):2045-9. PubMed ID: 19738211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OMERACT 11: international consensus conference on outcome measures in rheumatology.
    Simon LS; Strand V; Bingham CO; Singh JA
    J Rheumatol; 2014 Jan; 41(1):145-9. PubMed ID: 24382928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.